Medications for substance use disorders.

Medications for substance use disorders.
复制标题

DOI:
10.1080/19371918.2013.759031
复制
发表时间:
2013
影响因子:
2.5
通讯作者:
Sullivan C
Sullivan C
中科院分区:
医学4区
文献类型:
--
作者:
Douaihy AB;Kelly TM;Sullivan C

文献摘要

参考文献

被引文献

相似文献

在这篇文章中,作者简要回顾了目前可用于治疗药物使用障碍的药物治疗药物。尼古丁替代疗法对戒烟最有效。纳曲酮、阿坎普罗酸和双硫仑对减少酒精使用有效。阿片类药物使用障碍最有效的药物治疗是激动剂治疗,包括美沙酮和丁丙诺啡。作者还研究了其他物质使用障碍(如兴奋剂成瘾)的药物开发的最新进展。本文还讨论了药物依从性和行为治疗的作用,以及行为和药物治疗干预的整合。
In this article, the authors briefly review the pharmacotherapeutic agents that are currently available for the treatment of substance use disorders. Nicotine replacement therapies are most effective for tobacco cessation. Naltrexone, acamprosate, and disulfiram are effective for reducing alcohol use. The most effective pharmacotherapies for opiate use disorders are agonist therapies, including methadone and buprenorphine. The authors also examine recent advances in medication development for other substance use disorders such as stimulant addiction. The role of medication adherence and behavioral treatments and the integration of behavioral and pharmacotherapeutic interventions are also discussed.
DOI: 10.1016/j.drugalcdep.2011.09.026
发表时间: 2012-05-01
影响因子: 4.2
作者:
Carmody, Timothy P.;Delucchi, Kevin;Hall, Sharon M.
通讯作者: Hall, Sharon M.
DOI: 10.1111/j.1749-6632.2010.05900.x
发表时间: 2011-01-01
期刊: ADDICTION REVIEWS
影响因子: --
作者:
Gastfriend, David R.
通讯作者: Gastfriend, David R.
DOI: 10.1001/archpsyc.61.3.264
发表时间: 2004-03-01
影响因子: --
作者:
Carroll, KM;Fenton, LR;Rounsaville, BJ
通讯作者: Rounsaville, BJ
DOI: 10.1111/j.1360-0443.2006.01321.x
发表时间: 2006-02-01
期刊: ADDICTION
影响因子: 6
作者:
Fischer, G;Ortner, R;Aschauer, H
通讯作者: Aschauer, H
DOI: 10.1001/jama.293.13.1617
发表时间: 2005-04-06
影响因子: 120.7
作者:
Garbutt, JC;Kranzler, HR;Ehrich, EW
通讯作者: Ehrich, EW